These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging, and Treatment Management of Neuroendocrine Tumors. Deppen SA; Liu E; Blume JD; Clanton J; Shi C; Jones-Jackson LB; Lakhani V; Baum RP; Berlin J; Smith GT; Graham M; Sandler MP; Delbeke D; Walker RC J Nucl Med; 2016 May; 57(5):708-14. PubMed ID: 26769865 [TBL] [Abstract][Full Text] [Related]
14. A frequency and semiquantitative analysis of pathological 68Ga DOTATATE PET/CT uptake by primary site-dependent neuroendocrine tumor metastasis. Kunikowska J; Pawlak D; Kolasa A; Mikołajczak R; Królicki L Clin Nucl Med; 2014 Oct; 39(10):855-61. PubMed ID: 25072928 [TBL] [Abstract][Full Text] [Related]
15. Increased Activity Due to Fractures Does Not Significantly Affect the Accuracy of 68Ga-DOTATATE PET/CT in the Detection of Culprit Tumor in the Evaluation of Tumor-Induced Osteomalacia. Ding J; Hu G; Wang L; Li F; Huo L Clin Nucl Med; 2018 Dec; 43(12):880-886. PubMed ID: 30273206 [TBL] [Abstract][Full Text] [Related]
16. Evolution of a Schmorl's Node and a Degenerative Osteophyte on Sequential 68Ga-DOTATATE PET/CT Scans: Potential Pitfalls in Neuroendocrine Tumor Imaging. Hod N; Levin D; Anconina R; Benkovich E; Ezroh Kazap D; Lantsberg S Clin Nucl Med; 2019 Jan; 44(1):e40-e42. PubMed ID: 30418207 [TBL] [Abstract][Full Text] [Related]
17. Combined 18F-FDG PET/CT and 68Ga DOTATATE PET/CT "Superscan" in Metastatic Pancreatic Neuroendocrine Tumor. Chan M; Schembri GP Clin Nucl Med; 2017 Feb; 42(2):108-109. PubMed ID: 27997429 [TBL] [Abstract][Full Text] [Related]